GUYER WILLIAM (Chief Development Officer) sold 80.4% of their position (16.30K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $1.85M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/12/2026ACC: 0001193125-26-346942
Officer· Chief Development Officer
Since Aug 2021
-16.30K
Net shares
Net seller
$1.85M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
16.30K acquired · 32.60K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+16.30K
Price / share
$21.65
Trade value
$352.89K
% of position
409.0%
8/10/2026
3.98K→20.29K
Common Stock
Direct
Shares
−11.53K
Price / share
$113.18
Trade value
$1.30M
% of position
56.8%
8/10/2026
20.29K→8.76K
Common Stock
Direct
Shares
−4.77K
Price / share
$114.04
Trade value
$543.96K
% of position
54.5%
8/10/2026
8.76K→3.98K
Total
Net shares
+0.00
Net value
-$1.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2026 | M · Option Exercise | +16.30K | $21.65 | $352.89K | 409.0% | 3.98K | 20.29K |
| Common Stock Direct | 8/10/2026 | S · Sale | −11.53K | $113.18 | $1.30M | 56.8% | 20.29K | 8.76K |
| Common Stock Direct | 8/10/2026 | S · Sale | −4.77K | $114.04 | $543.96K | 54.5% | 8.76K | 3.98K |
| Total | +0.00 | -$1.50M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
16.30K shares
Shares
−16.30K
Strike price
21.65
Held after
110K
Exercisable
—
8/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock16.30K shares | 8/10/2026 | M · Option Exercise | −16.30K | 21.65 | — | 110K |